blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1198475

EP1198475 - HIGHLY PURIFIED CYTOKINE ACTIVATING FACTOR AND METHODS OF USE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  06.01.2006
Database last updated on 09.05.2025
Most recent event   Tooltip11.01.2008Lapse of the patent in a contracting state
New state(s): SE		published on 13.02.2008  [2008/07]
Applicant(s)For all designated states
Arkion Life Sciences LLC
3521 Silverside Road,Concord Plaza Quillen Building
Wilmington, DE 19810 / US
[N/P]
Former [2005/34]For all designated states
Arkion Life Sciences LLC
3521 Silverside Road,Concord Plaza Quillen Building
Wilmington, DE 19810 / US
Former [2002/17]For all designated states
Arkion Life Sciences
3521 Silverside Road, Quillen Building
Wilmington, DE 19810 / US
Inventor(s)01 / IYER, Subramanian
4 Homestead Lane
Hockessin, DE 19707 / US
02 / NGUYEN, Lance
10 Hillcrest Avenue
Telford, PA 18969 / US
03 / WU, Dauh-Rurng
1011 Sweet Cherry Court
Wilmington, DE 19809 / US
04 / XING, Ruye
25 Letchworth Ln
Avondale, PA19311-1337 / US
 [2002/47]
Former [2002/23]01 / IYER, Subramanian
4 Homestead Lane
Hockessin, DE 19707 / US
02 / NGUYEN, Lance
10 Hillcrest Avenue
Telford, PA 18969 / US
03 / WU, Dauh-Rurng
1502 Setan Villa Lane
Wilmington, DE 19809 / US
04 / XING, Ruye
25 Letchworth Ln
Avondale, PA19311-1337 / US
Former [2002/17]01 / IYER, Subramanian
4 Homestead Lane
Hockessin, DE 19707 / US
02 / NGUYEN, Lance
10 Hillcrest Avenue
Telford, PA 18969 / US
03 / WU, Dauh-Rurng
1502 Setan Villa Lane
Wilmington, DE 19809 / US
04 / XING, Ruye
5005 E. Woodmill Drive
Wilmington, DE 19808 / US
Representative(s)Howard, Paul Nicholas, et al
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2002/17]Howard, Paul Nicholas, et al
Carpmaels & Ransford 43 Bloomsbury Square
London WC1A 2RA / GB
Application number, filing date00947517.919.07.2000
[2002/17]
WO2000US19643
Priority number, dateUS19990145317P23.07.1999         Original published format: US 145317 P
US20000197619P14.04.2000         Original published format: US 197619 P
[2002/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0107472
Date:01.02.2001
Language:EN
[2001/05]
Type: A1 Application with search report 
No.:EP1198475
Date:24.04.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 01.02.2001 takes the place of the publication of the European patent application.
[2002/17]
Type: B1 Patent specification 
No.:EP1198475
Date:02.03.2005
Language:EN
[2005/09]
Search report(s)International search report - published on:US01.02.2001
(Supplementary) European search report - dispatched on:EP27.03.2003
ClassificationIPC:C07K14/46, C07K14/465, C07K14/47, C07K14/475, C07K16/18, C07K16/22, C12N5/10, C12N15/12, C12N15/63, C12N15/64, C12N15/83, A61K38/17, A61K38/18, A61K9/127, A61K9/48, A61K9/50
[2002/17]
CPC:
C07K14/465 (EP,US); A61P35/00 (EP); A61P37/00 (EP);
C07K14/46 (EP,US); A61K38/00 (EP,US); Y10S530/853 (EP,US)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/17]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:HOCHGEREINIGTER CYTOKIN-AKTIVIERENDER FAKTOR UND VERFAHREN ZU SEINER VERWENDUNG[2002/17]
English:HIGHLY PURIFIED CYTOKINE ACTIVATING FACTOR AND METHODS OF USE[2002/17]
French:FACTEUR D'ACTIVATION DE LA CYTOKINE HAUTEMENT PURIFIE ET PROCEDES D'UTILISATION[2002/17]
Entry into regional phase29.01.2002National basic fee paid 
29.01.2002Search fee paid 
29.01.2002Designation fee(s) paid 
29.01.2002Examination fee paid 
Examination procedure22.02.2001Request for preliminary examination filed
International Preliminary Examining Authority: US
29.01.2002Amendment by applicant (claims and/or description)
29.01.2002Examination requested  [2002/17]
30.07.2003Despatch of a communication from the examining division (Time limit: M04)
03.12.2003Reply to a communication from the examining division
23.12.2003Despatch of a communication from the examining division (Time limit: M04)
23.04.2004Reply to a communication from the examining division
14.06.2004Communication of intention to grant the patent
17.12.2004Fee for grant paid
17.12.2004Fee for publishing/printing paid
Opposition(s)05.12.2005No opposition filed within time limit [2006/08]
Fees paidRenewal fee
29.01.2002Renewal fee patent year 03
04.07.2003Renewal fee patent year 04
09.07.2004Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT02.03.2005
BE02.03.2005
FI02.03.2005
DK02.06.2005
GR02.06.2005
SE02.06.2005
CY19.07.2005
IE19.07.2005
LU19.07.2005
CH31.07.2005
LI31.07.2005
MC31.07.2005
PT17.08.2005
[2008/07]
Former [2007/26]AT02.03.2005
BE02.03.2005
FI02.03.2005
DK02.06.2005
GR02.06.2005
CY19.07.2005
IE19.07.2005
LU19.07.2005
CH31.07.2005
LI31.07.2005
MC31.07.2005
PT17.08.2005
Former [2007/20]AT02.03.2005
BE02.03.2005
FI02.03.2005
DK02.06.2005
GR02.06.2005
CY19.07.2005
IE19.07.2005
CH31.07.2005
LI31.07.2005
LU31.07.2005
MC31.07.2005
PT17.08.2005
Former [2007/08]AT02.03.2005
BE02.03.2005
FI02.03.2005
DK02.06.2005
GR02.06.2005
IE19.07.2005
CH31.07.2005
LI31.07.2005
LU31.07.2005
MC31.07.2005
PT17.08.2005
Former [2006/33]AT02.03.2005
BE02.03.2005
FI02.03.2005
DK02.06.2005
GR02.06.2005
IE19.07.2005
CH31.07.2005
LI31.07.2005
MC31.07.2005
PT17.08.2005
Former [2006/28]AT02.03.2005
BE02.03.2005
FI02.03.2005
DK02.06.2005
GR02.06.2005
IE19.07.2005
MC31.07.2005
PT17.08.2005
Former [2006/25]AT02.03.2005
BE02.03.2005
FI02.03.2005
DK02.06.2005
GR02.06.2005
IE19.07.2005
PT17.08.2005
Former [2006/14]AT02.03.2005
BE02.03.2005
FI02.03.2005
DK02.06.2005
GR02.06.2005
PT17.08.2005
Former [2006/13]AT02.03.2005
BE02.03.2005
FI02.03.2005
DK02.06.2005
Former [2005/51]AT02.03.2005
BE02.03.2005
FI02.03.2005
Former [2005/46]FI02.03.2005
Documents cited:Search   [ ] - No further relevant documents disclosed
International search[A]WO9305160  (ICI PLC [GB]);
 [A]WO9828419  (UNIV LELAND STANFORD JUNIOR [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.